Belén
Alfonso Bartolozzi
Ikertzailea 2017-(e)ra arte
Harvard Medical School
Boston, Estados UnidosHarvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2013
-
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization
Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 1, pp. 537-544